Risks associated with lamotrigine prescription: a review and personal observations.

CONCLUSIONS: While lamotrigine may be retrialled at a lower dose escalation rate following some skin reactions, it should not be recommenced following a SJS, TEN or DRESS reaction. Prescribers should be aware of quality control concerns about some available brands of lamotrigine. PMID: 29480028 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29480028?dopt=Abstract

Source: Australasian Psychiatry - February 1, 2018 Category: Psychiatry Authors: Parker G Tags: Australas Psychiatry Source Type: research

More News: Lamictal | Psychiatry | Skin | Toxicology